Capecitabine and Temozolomide in Patients with Advanced Pulmonary Carcinoid Tumours

<b><i>Background:</i></b> Temozolomide and capecitabine (CAPTEM) chemotherapy is known to be active in patients with pancreatic neuroendocrine tumours. <b><i>Objective:</i></b> This retrospective analysis set out to describe the efficacy and toxicity of CAPTEM in patients with advanced pulmonary carcinoids (PCs). <b><i>Methods:</i></b> Patients were included with advanced PC...